Monthly Prescribing Reference

Nipocalimab Can Delay, Prevent Anemia, Intrauterine Transfusion

Intravenous nipocalimab was administered from 14 to 35 weeks of gestation in participants with pregnancies at high risk for recurrent early-onset severe HDFN. HealthDay News — For pregnancies at high ...
Healio

Nipocalimab delays, prevents transfusions for pregnancies at risk for hemolytic disease

Please provide your email address to receive an email when new articles are posted on . Among pregnant women who received nipocalimab infusions, 54% had live births without an intrauterine transfusion ...
Science Daily

Drug trial for rare fetal blood disease shows promise for less invasive approach

Researchers are leading a study into nipocalimab, a new investigational drug that's showing promise in treating a rare blood disease in babies. It could help prevent anemia and cut down on the need ...
Hosted on MSN

Life-saving surgeries made locally accessible in two years

Rwanda’s health system is expanding its capacity to handle complex surgeries that were once only performed abroad. An example is an intrauterine transfusion at the University Teaching Hospital of ...